Great news! SeedBlink acquires Symbid.Learn more.
Press room

Technology at the service of Parkinson’s disease patients

Next on SeedBlink: PD Neurotechnology


Following the successful capital raising of BrainHero, we are pleased to announce the funding round of PD Neurotechnology, a Greek MedTech company addressing the second most common neurologic disease: Parkinson's Disease (PD).

This chronic neurodegenerative disease, for which there is no cure, affects an estimated 7 to 10 million people worldwide, up from 2.5 million in 1990.

"PD Monitor® is probably one of the most important steps forward in Parkinson's treatment in recent years and decades." said Per Odin, Professor of Neurology at Lund University, Sweden.

🗓️ This opportunity will be available with priority for selected investors and the SeedBlink Club members (get early access) on August 11, followed by a public launch on August 25.

We're excited to invite you on August 9 for the Pitch & Q&A online event with:

➢ Nikos Moschos - Co-Founder & CEO of PD Neurotechnology

➢ Aristos Doxiadis, Partner at BigPi

➢ Eric Bartha, Deal Captain, SeedBlink

Register now

Why we love PD Neurotechnology

  • PDN is a UK-based, ISO 13485 and 27001 certified medical device company founded in 2015.
  • In-house, fully developed R&D, manufacturing, support, medical trials, distribution, and sales and marketing functions.
  • Patented medical device technology based on AI and machine learning (2 owned, 2 in progress).
  • Launched in September 2020, PDMonitor® has generated traction among private patients and hospitals in Europe (G5), Sweden, Ireland, and Cyprus.
  • Clinical trials conducted in Germany, Italy, and Greece have confirmed the safety and performance of PDMonitor®, achieving over 95% accuracy in symptom detection.
  • Compliance with the Medical Device Directive (MDD - 93/42/EEC). FDA application in advanced progress.
  • Strong team expertise and world-class medical advisory board.
  • Series A round is led by CIC Capital Partners, the VC arm of Credit Mutuel – top 3 French insurance company.

PublishedAugust 05, 2022

Share on

Be the first to know all about tech-trends, European growth, investments, and get exclusive access to all resources offered by our community!

Related articles


Diwaker Singh

Co-Founder & CEO


As a platform that only serves technology ventures, SeedBlink can connect the start-up with more than just money. SeedBlink investors are primarily technocrats who understand the objectives of the fundraising company and are also able to post-funding contribute with business opportunities. The minimum investment threshold, and technology focus, differentiates SeedBlink from other fundraising platforms. A perfect fit for a technology start-up seeking intelligent funding.


Florin Stoian

Co-Founder & CEO


SeedBlink boosted our brand exposure and facilitated the financial support we were seeking. Having a campaign on the platform allowed us not only to meet a team of professionals - that guided and helped us prepare the necessary materials - but also opened doors for increasing our brand awareness and have discussions with VCs & angel investors we have never reached before. This campaign gave us the encouragement we needed to push the product further, while the record-breaking fundraising (only 2 hours from the launch of the campaign!) was a great confirmation that our product is needed in this market and that we should continue innovating.


Raluca Jianu

CEO & Co-founder

Epic Visits

SeedBlink has created a vital ecosystem for startups at the beginning of their journey by equipping entrepreneurs with expertise, encouraging honest and sometimes uncomfortable but necessary discussions about risks and vulnerabilities through a suite of tools, and facilitating connections with investors who share the founders' vision and can contribute to their success. I have greatly appreciated the constant support of Eric and the entire team at all stages of the campaign. Thank you so much!